Innospec Stock Analysis

IOSP Stock  USD 81.41  2.15  2.71%   
Below is the normalized historical share price chart for Innospec extending back to May 13, 1998. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Innospec stands at 81.41, as last reported on the 30th of January, with the highest price reaching 81.64 and the lowest price hitting 78.97 during the day.
IPO Date
13th of May 1998
200 Day MA
81.6571
50 Day MA
77.1874
Beta
0.897
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Innospec holds a debt-to-equity ratio of 0.046. At this time, Innospec's Short Term Debt is relatively stable compared to the past year. As of 01/30/2026, Long Term Debt is likely to grow to about 127.3 M, while Long Term Debt Total is likely to drop slightly above 109.2 K. Innospec's financial risk is the risk to Innospec stockholders that is caused by an increase in debt.

Asset vs Debt

Equity vs Debt

Innospec's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Innospec's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Innospec Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Innospec's stakeholders.
For most companies, including Innospec, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Innospec, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Innospec's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book
1.5142
Enterprise Value Ebitda
8.8565
Price Sales
1.1299
Shares Float
24.5 M
Dividend Share
1.63
At this time, Innospec's Total Stockholder Equity is relatively stable compared to the past year. As of 01/30/2026, Stock Based Compensation is likely to grow to about 10 M, while Other Stockholder Equity is likely to drop slightly above 261.2 M. . As of 01/30/2026, Price Earnings Ratio is likely to grow to 72.84, while Price To Sales Ratio is likely to drop 0.76.
Innospec is undervalued with Real Value of 89.08 and Target Price of 99.33. The main objective of Innospec stock analysis is to determine its intrinsic value, which is an estimate of what Innospec is worth, separate from its market price. There are two main types of Innospec's stock analysis: fundamental analysis and technical analysis.
The Innospec stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Innospec is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Innospec Stock trading window is adjusted to America/New York timezone.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innospec. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Innospec Stock, please use our How to Invest in Innospec guide.

Innospec Stock Analysis Notes

About 100.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.51. Some equities with similar Price to Book (P/B) outperform the market in the long run. Innospec recorded a loss per share of 0.04. The entity last dividend was issued on the 18th of November 2025. The firm had 2:1 split on the 23rd of July 2007. Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado. Innospec operates under Specialty Chemicals classification in the United States and is traded on NASDAQ Exchange. It employs 1900 people. To learn more about Innospec call Patrick Williams at 303 792 5554 or check out https://innospec.com.

Innospec Quarterly Total Revenue

441.9 Million

Innospec Investment Alerts

Over 100.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Global Emollient Market to Reach USD 4.08 Billion by 2030 with Rising Demand for Skincare Products

Innospec Largest EPS Surprises

Earnings surprises can significantly impact Innospec's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2002-02-12
2001-12-310.140.160.0214 
2001-10-29
2001-09-300.120.140.0216 
2001-04-30
2001-03-310.080.06-0.0225 
View All Earnings Estimates

Innospec Environmental, Social, and Governance (ESG) Scores

Innospec's ESG score is a quantitative measure that evaluates Innospec's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Innospec's operations that may have significant financial implications and affect Innospec's stock price as well as guide investors towards more socially responsible investments.

Innospec Stock Institutional Investors

Shares
Charles Schwab Investment Management Inc2025-06-30
356.2 K
Millennium Management Llc2025-06-30
350 K
Jpmorgan Chase & Co2025-06-30
321.2 K
Qube Research & Technologies2025-06-30
306.8 K
Northern Trust Corp2025-06-30
302.5 K
Nuveen, Llc2025-06-30
296 K
Bank Of America Corp2025-06-30
295.5 K
Morgan Stanley - Brokerage Accounts2025-06-30
263.8 K
Hhg Plc2025-06-30
255.4 K
Blackrock Inc2025-06-30
3.7 M
Vanguard Group Inc2025-06-30
3.2 M
Note, although Innospec's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Innospec Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.02 B.

Innospec Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets 0.02  0.02 
Return On Capital Employed 0.12  0.10 
Return On Assets 0.02  0.02 
Return On Equity 0.03  0.03 

Management Efficiency

As of 01/30/2026, Return On Tangible Assets is likely to drop to 0.02. In addition to that, Return On Capital Employed is likely to drop to 0.1. At this time, Innospec's Non Current Liabilities Total is relatively stable compared to the past year. As of 01/30/2026, Change To Liabilities is likely to grow to about 78.1 M, while Total Current Liabilities is likely to drop slightly above 240.4 M. Innospec's management efficiency ratios could be used to measure how well Innospec manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share 43.90  46.09 
Tangible Book Value Per Share 27.73  29.12 
Enterprise Value Over EBITDA 10.02  5.91 
Price Book Value Ratio 2.04  1.33 
Enterprise Value Multiple 10.02  5.91 
Price Fair Value 2.04  1.33 
Enterprise Value1.7 B1.7 B
Leadership at Innospec emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Dividend Yield
0.0206
Operating Margin
0.0701
Profit Margin
(0.0007)
Forward Dividend Yield
0.0214
Beta
0.897

Technical Drivers

As of the 30th of January, Innospec retains the Risk Adjusted Performance of 0.0674, market risk adjusted performance of 0.1341, and Downside Deviation of 1.26. Innospec technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Innospec Price Movement Analysis

Execute Study
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Innospec middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Innospec. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Innospec Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Innospec insiders, such as employees or executives, is commonly permitted as long as it does not rely on Innospec's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Innospec insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Innospec Predictive Daily Indicators

Innospec intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Innospec stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Innospec Corporate Filings

F4
17th of November 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
5th of November 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
6th of August 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
30th of May 2025
Other Reports
ViewVerify
F4
15th of May 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
14th of May 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
13th of May 2025
An amended filing to the original Schedule 13G
ViewVerify
8K
9th of May 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Innospec Forecast Models

Innospec's time-series forecasting models are one of many Innospec's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Innospec's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Innospec Debt to Cash Allocation

Innospec currently holds 44.9 M in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. Innospec has a current ratio of 2.12, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Innospec's use of debt, we should always consider it together with its cash and equity.

Innospec Total Assets Over Time

Innospec Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Innospec uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Innospec Debt Ratio

    
  2.83   
It seems most of the Innospec's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Innospec's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Innospec, which in turn will lower the firm's financial flexibility.

Innospec Short Long Term Debt Total

Short Long Term Debt Total

38.39 Million

At this time, Innospec's Short and Long Term Debt Total is relatively stable compared to the past year.

About Innospec Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Innospec prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Innospec shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Innospec. By using and applying Innospec Stock analysis, traders can create a robust methodology for identifying Innospec entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.03  0.02 
Operating Profit Margin 0.10  0.11 
Net Profit Margin 0.02  0.02 
Gross Profit Margin 0.34  0.39 

Current Innospec Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Innospec analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Innospec analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
99.33Strong Buy2Odds
Innospec current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Innospec analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Innospec stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Innospec, talking to its executives and customers, or listening to Innospec conference calls.
Innospec Analyst Advice Details

Innospec Stock Analysis Indicators

Innospec stock analysis indicators help investors evaluate how Innospec stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Innospec shares will generate the highest return on investment. By understating and applying Innospec stock analysis, traders can identify Innospec position entry and exit signals to maximize returns.
Begin Period Cash Flow203.7 M
Common Stock Shares Outstanding25.1 M
Total Stockholder Equity1.2 B
Total Cashflows From Investing Activities-62 M
Tax Provision5.6 M
Quarterly Earnings Growth Y O Y-0.609
Property Plant And Equipment Net314.5 M
Cash And Short Term Investments289.2 M
Cash289.2 M
Accounts Payable163.8 M
Net Debt-244.3 M
50 Day M A77.1874
Total Current Liabilities371.4 M
Other Operating Expenses1.7 B
Non Current Assets Total778.1 M
Forward Price Earnings14.2653
Non Currrent Assets Other6.3 M
Stock Based Compensation8.5 M

Additional Tools for Innospec Stock Analysis

When running Innospec's price analysis, check to measure Innospec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innospec is operating at the current time. Most of Innospec's value examination focuses on studying past and present price action to predict the probability of Innospec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innospec's price. Additionally, you may evaluate how the addition of Innospec to your portfolios can decrease your overall portfolio volatility.